DK1272617T3 - Prostata cellelinier og deres anvendelse - Google Patents

Prostata cellelinier og deres anvendelse

Info

Publication number
DK1272617T3
DK1272617T3 DK01917257.6T DK01917257T DK1272617T3 DK 1272617 T3 DK1272617 T3 DK 1272617T3 DK 01917257 T DK01917257 T DK 01917257T DK 1272617 T3 DK1272617 T3 DK 1272617T3
Authority
DK
Denmark
Prior art keywords
cell lines
prostate
disease
prostate cell
onycap23
Prior art date
Application number
DK01917257.6T
Other languages
English (en)
Inventor
Peter Thraves
Andrew Sutton
Original Assignee
Onyvax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0008032A external-priority patent/GB0008032D0/en
Priority claimed from GB0024237A external-priority patent/GB0024237D0/en
Application filed by Onyvax Ltd filed Critical Onyvax Ltd
Application granted granted Critical
Publication of DK1272617T3 publication Critical patent/DK1272617T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK01917257.6T 2000-04-01 2001-03-30 Prostata cellelinier og deres anvendelse DK1272617T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0008032A GB0008032D0 (en) 2000-04-01 2000-04-01 New prostate cell lines
GB0024237A GB0024237D0 (en) 2000-10-03 2000-10-03 New prostate cell lines
PCT/GB2001/001437 WO2001075073A2 (en) 2000-04-01 2001-03-30 Prostate cell lines and their use

Publications (1)

Publication Number Publication Date
DK1272617T3 true DK1272617T3 (da) 2011-08-22

Family

ID=26244016

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01917257.6T DK1272617T3 (da) 2000-04-01 2001-03-30 Prostata cellelinier og deres anvendelse

Country Status (9)

Country Link
US (1) US7303911B2 (da)
EP (1) EP1272617B1 (da)
AT (1) ATE507285T1 (da)
AU (1) AU2001244341A1 (da)
CA (1) CA2404388C (da)
DE (1) DE60144515D1 (da)
DK (1) DK1272617T3 (da)
HK (1) HK1052531A1 (da)
WO (1) WO2001075073A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050019336A1 (en) 2003-07-23 2005-01-27 Dalgleish Angus George Human prostate cell lines in cancer treatment
DE102004038076A1 (de) * 2004-02-16 2005-09-01 Proteosys Ag Diagnostische Marker für Krebs
WO2005078124A2 (de) * 2004-02-16 2005-08-25 Proteosys Ag Diagnostische marker für krebs
WO2021113328A1 (en) 2019-12-03 2021-06-10 Neuvogen, Inc. Tumor cell vaccines

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368593B1 (en) 1997-10-10 2002-04-09 The Regents Of The University Of California Enhanced immunogenic cell populations prepared using H2 receptor antagonists
CA2237391A1 (en) 1995-11-15 1997-05-22 University Of Utah Novel method of culturing human epithelial cells for the identification of cancer therapeutics and diagnostics
DE69627527T2 (de) 1995-12-28 2004-03-04 The Johns Hopkins University School Of Medicine Allogene parakrine cytokine tumor impfstoffe
CA2245099C (en) * 1996-02-02 2007-01-09 Suzanne L. Topalian Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer
KR20000049096A (ko) 1996-10-11 2000-07-25 린다 에스. 스티븐슨 혼합 림프구와 조합된 종양세포를 사용하는 암 면역요법
US5804443A (en) * 1997-02-28 1998-09-08 Bernofsky; Carl Human monocytic leukemia cell line
DE19832840C1 (de) 1998-07-21 2000-06-08 Kerkmann Tucek Aida Mittel zur Immuntherapie von Tumorerkrankungen
GB9827103D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
EP1178822B1 (en) * 1999-05-21 2004-02-18 Onyvax Limited Whole cell cancer vaccine comprising co-cultured malignant and non-malignant cells

Also Published As

Publication number Publication date
HK1052531A1 (en) 2003-09-19
CA2404388C (en) 2010-06-15
AU2001244341A1 (en) 2001-10-15
DE60144515D1 (de) 2011-06-09
WO2001075073A3 (en) 2002-02-14
EP1272617A2 (en) 2003-01-08
EP1272617B1 (en) 2011-04-27
US7303911B2 (en) 2007-12-04
CA2404388A1 (en) 2001-10-11
US20030185808A1 (en) 2003-10-02
WO2001075073A2 (en) 2001-10-11
ATE507285T1 (de) 2011-05-15

Similar Documents

Publication Publication Date Title
Cyrus et al. Turbidity and salinity in a tropical northern Australian estuary and their influence on fish distribution
BR0108685A (pt) Marcadores relacionados com endometriose
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
FR2828206B1 (fr) Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
CY1106289T1 (el) Χρηση αναστολεων υποδοχεος προγεστepονης για τη θepαπευτικη αντιμετωπιση του καρκινου του μαστου που ειναι ανθεκτικος σε στepοειδη
MXPA02012042A (es) Compuestos efectivos como agonistas de beta-2-adrenorreceptor, y como inhibidores de pde4.
DK1546327T3 (da) Udvælgelse og isolation af levende celler ved brug af RNA-bindingssonder
DK1272617T3 (da) Prostata cellelinier og deres anvendelse
EE04581B1 (et) a1 ß1-integriiniretseptori inhibiitorite ja TGF-ß1 inhibiitorite kasutamine neeruhaiguse ravis
BR9907025B1 (pt) Polissacarídeos sintéticos e uso dos mesmos
IL158147A0 (en) Methods and cells for identifying cancer-related genes
TR200200169T2 (tr) IL-18 inhibitörlerinin kullanımı.
ATE441710T1 (de) Antisense oligonukleotide, die die ausprägungsstufe von hif-1 hemmen
Daniels et al. Cheilolejeunea trapezia (Nees) Kachroo & RM Schust. ex Mizut. var. ceylanica (Gottsche) AED Daniels & KC Kariyappa comb. et stat. nov.(Lejeuneaceae) from India
NO20040174L (no) Fremgangsmate for donorspesifikk krysstilpasning
DK0898708T3 (da) Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays
TR199901546A2 (xx) Pirolidinil hidroksamik asid bile�imleri i�in y�ntem.
ATE480237T1 (de) Tumorhemmende nitroacridin-zusammensetzungen
Sarsini L'azione delle donne nella Costituente
IT1319665B1 (it) Addotti di corticosteroidi con polimeri polisaccaridici naturali.
Aizawa et al. CHANGES OF AGRICULTURAL COMMUNITY AND REGIONAL ECONOMY SCE, 1-1
Gabbert In vivo observations on tumor invasion
Lockie Private finance initiative(PFI): the lost green ticket?
Coulter Construction braces itself for world slump
UA67624A (en) Method for assessing social disadaptation in patients with vegetative dystonia